Protein programmers get a helping hand from Cradle’s generative AI

Proteins are the molecules that get work done in nature, and there’s a whole industry emerging around successfully modifying and manufacturing them for various uses. But doing so is time consumi

Manifold Bio’s molecular ‘barcodes’ could break through pharma’s in vivo bottleneck

In the creation of a new drug, there comes a point where you have to finally put the molecule in a real creature — one at a time — and see if it actually does what you think it does. Manifold Bio&

Maolac pours new funding into superfood mimicking breast milk health benefits

The company identifies and extracts functional proteins from bovine colostrum and uses them to make milk protein mixtures that could be used for different immune-boosting applications.

With $8M seed round, Protai leverages the proteome to speed up drug discovery

Tech is an increasingly important part of the complex drug discovery and testing process, and with advances in processing power and algorithms it is tapping new areas for analysis. Proteomics, the dom

AI proves a dab hand at pure mathematics and protein hallucination

One of the reasons artificial intelligence is such an interesting field is that pretty much no one knows what it might turn out to be good at. Two papers by leading labs published in the journal Natur

Immunai announces a $215M Series B as its ‘immune cell atlas’ matures

Biotech startup Immunai has been on a roll when it comes to funding. The company that set out to create an atlas of the human immune system in 2018 had raised about $80 million by February 2021. On We

Glyphic Biotechnologies raises $6M to accelerate protein sequencing by orders of magnitude

The whole human proteome may be free to browse thanks to DeepMind, but at the bleeding edge of biotech new proteins are made and tested every day, a complex and time-consuming process. Glyphic Biotech